Convection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant glioma

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 10, Issue 1, 2014, Pages 149-157

  Bernal, Giovanna M ^a   LaRiviere, Michael J ^a   Mansour, Nassir ^a   Pytel, Peter ^a   Cahill, Kirk E ^a   Voce, David J ^a   Kang, Shijun ^a   Spretz, Ruben ^c   Welp, Ulrich ^d   Noriega, Sandra E ^c   Nuñez, Luis ^c   Larsen, Gustavo ^c   Weichselbaum, Ralph R ^b   Yamini, Bakhtiar ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c LNKChemsolutions   (United States)

^d ARGONNE NATIONAL LABORATORY   (United States)

Author keywords

Convection; Glioma; MRI; Nanoparticle

Indexed keywords

CHEMOTHERAPEUTIC AGENTS; CONVECTION-ENHANCED DELIVERY; GLIOMA; IMAGE-GUIDED TREATMENTS; MULTIFUNCTIONAL PLATFORMS; NANOPARTICLE PROPERTIES; POLYMERIC NANOPARTICLES; THERAPEUTIC AGENTS;

ANIMALS; BIOLOGICAL MATERIALS; EMULSIFICATION; FUNCTIONAL POLYMERS; HEAT CONVECTION; IRON OXIDES; MAGNETIC RESONANCE IMAGING; MOLECULAR BIOLOGY; TUMORS;

NANOPARTICLES;

IRON OXIDE; NANOCARRIER; POLYMERIC MAGNETITE BEARING NANOPARTICLE; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; CONVECTION ENHANCED DELIVERY; DECOMPOSITION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; ENDOCYTOSIS; GLIOBLASTOMA; GLIOMA CELL; IN VIVO STUDY; MALE; MOLECULAR IMAGING; MOUSE; NANOFABRICATION; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; TUMOR XENOGRAFT;

ANIMALIA; RODENTIA;

CONVECTION; GLIOMA; MRI; NANOPARTICLE;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CONVECTION; DACARBAZINE; DRUG DELIVERY SYSTEMS; FERRIC COMPOUNDS; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; NANOPARTICLES; POLYMERS; RATS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84891016613     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2013.07.003     Document Type: Article

References (29)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62:10-29.
2. Paszat L., Laperriere N., Groome P., Schulze K., Mackillop W., Holowaty E. A population-based study of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 2001, 51:100-107.
3. Hess C.F., Schaaf J.C., Kortmann R.D., Schabet M., Bamberg M. Malignant glioma: patterns of failure following individually tailored limited volume irradiation. Radiother Oncol 1994, 30:146-149.
4. Stewart L.A. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 2002, 359:1011-1018.
5. Bobo R.H., Laske D.W., Akbasak A., Morrison P.F., Dedrick R.L., Oldfield E.H. Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci USA 1994, 91:2076-2080.
6. Ferguson S.D., Foster K., Yamini B. Convection-enhanced delivery for treatment of brain tumors. Expert Rev Anticancer Ther 2007, 7:S79-S85.
7. Kunwar S., Kunwar M., Kunwar M., Kunwar J., Barnett G., et al. Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma. Neuro Oncol 2010, 12:871-881.
8. Fiandaca M.S., Forsayeth J.R., Dickinson P.J., Bankiewicz K.S. Image-guided convection-enhanced delivery platform in the treatment of neurological diseases. Neurotherapeutics 2008, 5:123-127.
9. Linninger A.A., Somayaji M.R., Mekarski M., Zhang L. Prediction of convection-enhanced drug delivery to the human brain. J Theor Biol 2008, 250:125-138.
10. Raghavan R., Brady M.L., Rodriguez-Ponce M.I., Hartlep A., Pedain C., Sampson J.H. Convection-enhanced delivery of therapeutics for brain disease, and its optimization. Neurosurg Focus 2006, 20:E12.
11. Wu Q.J., Li T., Wu Q., Yin F.F. Adaptive radiation therapy: technical components and clinical applications. Cancer J 2011, 17:182-189.
12. El-Aneed A. An overview of current delivery systems in cancer gene therapy. J Control Release 2004, 94:1-14.
13. Hofheinz R.D., Gnad-Vogt S.U., Beyer U., Hochhaus A. Liposomal encapsulated anti-cancer drugs. Anticancer Drugs 2005, 16:691-707.
14. Allard E., Passirani C., Benoit J.P. Convection-enhanced delivery of nanocarriers for the treatment of brain tumors. Biomaterials 2009, 30(12):2302-2318.
15. Chen M.Y., Hoffer A., Morrison P.F., Hamilton J.F., Hughes J., Schlageter K.S., et al. Surface properties, more than size, limiting convective distribution of virus-sized particles and viruses in the central nervous system. J Neurosurg 2005, 103:311-319.
16. Yamini B., Yu X., Gillespie G.Y., Kufe D.W., Weichselbaum R.R. Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastoma. Cancer Res 2004, 64:6381-6384.
17. Babu N.J., Sanphui P., Nangia A. Crystal engineering of stable temozolomide cocrystals. Chem Asian J 2012, 7:2274-2285.
18. Krauze M.T., Saito R., Noble C., Tamas M., Bringas J., Park J.W., et al. Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agents. J Neurosurg 2005, 103:923-929.
19. Rothen-Rutishauser B., Kuhn D.A., Ali Z., Gasser M., Amin F., Parak W.J., et al. Quantification of gold nanoparticle cell uptake under controlled biological conditions and adequate resolution. Nanomedicine (Lond) 2013, Advance online publication. http://dx.doi.org/10.2217/nnm.13.24.
20. Carroll R.C., Beattie E.C., Xia H., Luscher C., Altschuler Y., Nicoll R.A., et al. Dynamin-dependent endocytosis of ionotropic glutamate receptors. Proc Natl Acad Sci USA 1999, 96:14112-14117.
21. MacKay J.A., Deen D.F., Szoka F.C. Distribution in brain of liposomes after convection enhanced delivery; modulation by particle charge, particle diameter, and presence of steric coating. Brain Res 2005, 1035:139-153.
22. Vavra M., Ali M.J., Kang E.W., Navalitloha Y., Ebert A., Allen C.V., et al. Comparative pharmacokinetics of 14C-sucrose in RG-2 rat gliomas after intravenous and convection-enhanced delivery. Neuro Oncol 2004, 6:104-112.
23. Sampson J.H., Archer G., Pedain C., Wembacher-Schroder E., Kunwar S., et al. Poor drug distribution as a possible explanation for the results of the PRECISE trial. J Neurosurg 2010, 13:301-309.
24. Hadjipanayis C.G., Machaidze R., Kaluzova M., Wang L., Schuette A.J., Chen H., et al. EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma. Cancer Res 2010, 70:6303-6312.
25. Singh N., Jenkins G.J., Asadi R., Doak S.H. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Reviews 2010, 1. Published online. http://dx.doi.org/ 10.3402/nano.v1i0.5358.
26. Hoskins C., Cuschieri A., Wang L. The cytotoxicity of polycationic iron oxide nanoparticles: common endpoint assays and alternative approaches for improved understanding of cellular response mechanism. J Nanobiotechnol 2012, 10:15.
27. Gupta A.K., Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26:3995-4021.
28. Muldoon L.L., Sandor M., Pinkston K.E., Neuwelt E.A. Imaging, distribution, and toxicity of superparamagnetic iron oxide magnetic resonance nanoparticles in the rat brain and intracerebral tumor. Neurosurgery 2005, 57:785-796. [discussion 85-96].
29. Dickinson P.J., LeCouteur R.A., Higgins R.J., Bringas J.R., Larson R.F., Yamashita Y., et al. Canine spontaneous glioma: a translational model system for convection-enhanced delivery. Neuro Oncol 2010, 12:928-940.